{"pmid":32282977,"title":"First case of COVID-19 in a kidney transplant recipient treated with belatacept.","text":["First case of COVID-19 in a kidney transplant recipient treated with belatacept.","Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing public health emergency of international concern. Acute respiratory distress syndrome (ARDS) develops in 3-30% of patients with COVID-19 (1,2), because of direct virus-induced cytopathic effects in the respiratory tract or cytokine storms triggered by the host's immune response. Comorbidities are known to increase the risk of ARDS in SARS-CoV-2-infected patients (1).","Am J Transplant","Marx, David","Moulin, Bruno","Fafi-Kremer, Samira","Benotmane, Ilies","Gautier, Gabriela","Perrin, Peggy","Caillard, Sophie","32282977"],"abstract":["Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an ongoing public health emergency of international concern. Acute respiratory distress syndrome (ARDS) develops in 3-30% of patients with COVID-19 (1,2), because of direct virus-induced cytopathic effects in the respiratory tract or cytokine storms triggered by the host's immune response. Comorbidities are known to increase the risk of ARDS in SARS-CoV-2-infected patients (1)."],"journal":"Am J Transplant","authors":["Marx, David","Moulin, Bruno","Fafi-Kremer, Samira","Benotmane, Ilies","Gautier, Gabriela","Perrin, Peggy","Caillard, Sophie"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32282977","week":"202016|Apr 13 - Apr 19","doi":"10.1111/ajt.15919","source":"PubMed","topics":["Case Report"],"weight":1,"_version_":1663989232510697473,"score":7.979339,"similar":[{"pmid":32220017,"title":"Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.","text":["Perioperative Presentation of COVID-19 Disease in a Liver Transplant Recipient.","Coronavirus disease 2019 (COVID-19) is highly contagious. It may rapidly progress to acute respiratory distress syndrome (ARDS) and result in multiorgan dysfunction or death in some cases.((1,2)) Here, we report the case of a patient with hepatocellular carcinoma (HCC) who underwent liver transplantation and experienced COVID-19 infection during the perioperative period. This case may help clinicians by alerting them to potential COVID-19 infection in transplant recipients during the outbreak.","Hepatology","Qin, Juanjuan","Wang, Haitao","Qin, Xuan","Zhang, Peng","Zhu, Lihua","Cai, Jingjing","Yuan, Yufeng","Li, Hongliang","32220017"],"abstract":["Coronavirus disease 2019 (COVID-19) is highly contagious. It may rapidly progress to acute respiratory distress syndrome (ARDS) and result in multiorgan dysfunction or death in some cases.((1,2)) Here, we report the case of a patient with hepatocellular carcinoma (HCC) who underwent liver transplantation and experienced COVID-19 infection during the perioperative period. This case may help clinicians by alerting them to potential COVID-19 infection in transplant recipients during the outbreak."],"journal":"Hepatology","authors":["Qin, Juanjuan","Wang, Haitao","Qin, Xuan","Zhang, Peng","Zhu, Lihua","Cai, Jingjing","Yuan, Yufeng","Li, Hongliang"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220017","week":"202013|Mar 23 - Mar 29","doi":"10.1002/hep.31257","source":"PubMed","locations":["multiorgan"],"topics":["Case Report"],"weight":1,"_version_":1663352135042990081,"score":201.86443},{"pmid":32233067,"title":"COVID-19 in Kidney Transplant Recipients.","text":["COVID-19 in Kidney Transplant Recipients.","An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions. After China, Italy is the country with the highest number of cases so far (41,035 confirmed cases according to Dipartimento della Protezione Civile as of March 19, and 3,405 deaths). In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patients are getting infected and starting to develop coronavirus disease 2019 (COVID-19).","Am J Transplant","Gandolfini, Ilaria","Delsante, Marco","Fiaccadori, Enrico","Zaza, Gianluigi","Manenti, Lucio","Degli Antoni, Anna","Peruzzi, Licia","Riella, Leonardo V","Cravedi, Paolo","Maggiore, Umberto","32233067"],"abstract":["An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that began in Wuhan, China, has spread rapidly and has already taken on pandemic proportions. After China, Italy is the country with the highest number of cases so far (41,035 confirmed cases according to Dipartimento della Protezione Civile as of March 19, and 3,405 deaths). In Northern Italy, where the current prevalence of confirmed cases has surpassed in some areas 2 per 1,000 people, kidney transplant patients are getting infected and starting to develop coronavirus disease 2019 (COVID-19)."],"journal":"Am J Transplant","authors":["Gandolfini, Ilaria","Delsante, Marco","Fiaccadori, Enrico","Zaza, Gianluigi","Manenti, Lucio","Degli Antoni, Anna","Peruzzi, Licia","Riella, Leonardo V","Cravedi, Paolo","Maggiore, Umberto"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233067","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15891","source":"PubMed","locations":["Italy","Wuhan","China","Dipartimento"],"countries":["China","Italy"],"countries_codes":["CHN|China","ITA|Italy"],"topics":["Case Report"],"weight":1,"_version_":1663352135328202753,"score":167.3872},{"pmid":32243672,"title":"SARS Cov2 infection in a renal transplanted patients. A case report.","text":["SARS Cov2 infection in a renal transplanted patients. A case report.","The clinical manifestation of COVID-19 can vary from an asymptomatic course to ARDS requiring invasive mechanical ventilation and extracorporeal membrane oxygenation. A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression. It is possible that Immunosuppression can \"be protective\" as the cytokine storm is an important factor in the disease story. Despite the good outcome reported in the present case report, is remains of vital importance the solid organ transplant patients use precautions in order to avoid the infection.","Am J Transplant","Seminari, Elena","Colaneri, Marta","Sambo, Margherita","Gallazzi, Ilaria","Di Matteo, Angela","Silvia, Roda","Bruno, Raffaele","32243672"],"abstract":["The clinical manifestation of COVID-19 can vary from an asymptomatic course to ARDS requiring invasive mechanical ventilation and extracorporeal membrane oxygenation. A kidney transplanted patient infected with SARS CoV2 infection showed a mild disease despite immune suppression. It is possible that Immunosuppression can \"be protective\" as the cytokine storm is an important factor in the disease story. Despite the good outcome reported in the present case report, is remains of vital importance the solid organ transplant patients use precautions in order to avoid the infection."],"journal":"Am J Transplant","authors":["Seminari, Elena","Colaneri, Marta","Sambo, Margherita","Gallazzi, Ilaria","Di Matteo, Angela","Silvia, Roda","Bruno, Raffaele"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32243672","week":"202014|Mar 30 - Apr 05","doi":"10.1111/ajt.15902","source":"PubMed","locations":["Cov2"],"topics":["Case Report"],"weight":1,"_version_":1663352135807401984,"score":160.37347},{"pmid":32267560,"title":"Considerations for statin therapy in patients with COVID-19.","text":["Considerations for statin therapy in patients with COVID-19.","Current coronavirus pandemic named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the third coronavirus outbreak during the current century after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses.(1) Acute respiratory distress syndrome (ARDS) is an immunopathologic event and main cause of death following COVID-19. The main mechanism of ARDS is uncontrolled systemic inflammatory response and cytokine storm following release of proinflammatory cytokines (such as interferons (IFN), interleukines (IL), tumor necrosis factor (TNF)-alpha) and chemokines.(2-3) So, some Chinese researchers proposed or used anti-inflammatory agents in the treatment regimen of patients with COVID-19.(3-4).","Pharmacotherapy","Dashti-Khavidaki, Simin","Khalili, Hossein","32267560"],"abstract":["Current coronavirus pandemic named coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is the third coronavirus outbreak during the current century after severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronaviruses.(1) Acute respiratory distress syndrome (ARDS) is an immunopathologic event and main cause of death following COVID-19. The main mechanism of ARDS is uncontrolled systemic inflammatory response and cytokine storm following release of proinflammatory cytokines (such as interferons (IFN), interleukines (IL), tumor necrosis factor (TNF)-alpha) and chemokines.(2-3) So, some Chinese researchers proposed or used anti-inflammatory agents in the treatment regimen of patients with COVID-19.(3-4)."],"journal":"Pharmacotherapy","authors":["Dashti-Khavidaki, Simin","Khalili, Hossein"],"date":"2020-04-09T11:00:00Z","year":2020,"_id":"32267560","week":"202015|Apr 06 - Apr 12","doi":"10.1002/phar.2397","keywords":["COVID-19","Coronavirus infection","HMG-CoA reductase inhibitor","SARS-CoV","Statin"],"source":"PubMed","locations":["Chinese"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663609715717832705,"score":159.15813},{"pmid":32217117,"pmcid":"PMC7102583","title":"COVID-19: Melatonin as a potential adjuvant treatment.","text":["COVID-19: Melatonin as a potential adjuvant treatment.","This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory disorder induced by either highly homogenous coronaviruses or other pathogens, the evidence suggests that excessive inflammation, oxidation, and an exaggerated immune response very likely contribute to COVID-19 pathology. This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens. Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes for COVID-19 patients. Notably, melatonin has a high safety profile. There is significant data showing that melatonin limits virus-related diseases and would also likely be beneficial in COVID-19 patients. Additional experiments and clinical studies are required to confirm this speculation.","Life Sci","Zhang, Rui","Wang, Xuebin","Ni, Leng","Di, Xiao","Ma, Baitao","Niu, Shuai","Liu, Changwei","Reiter, Russel J","32217117"],"abstract":["This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory disorder induced by either highly homogenous coronaviruses or other pathogens, the evidence suggests that excessive inflammation, oxidation, and an exaggerated immune response very likely contribute to COVID-19 pathology. This leads to a cytokine storm and subsequent progression to acute lung injury (ALI)/acute respiratory distress syndrome (ARDS) and often death. Melatonin, a well-known anti-inflammatory and anti-oxidative molecule, is protective against ALI/ARDS caused by viral and other pathogens. Melatonin is effective in critical care patients by reducing vessel permeability, anxiety, sedation use, and improving sleeping quality, which might also be beneficial for better clinical outcomes for COVID-19 patients. Notably, melatonin has a high safety profile. There is significant data showing that melatonin limits virus-related diseases and would also likely be beneficial in COVID-19 patients. Additional experiments and clinical studies are required to confirm this speculation."],"journal":"Life Sci","authors":["Zhang, Rui","Wang, Xuebin","Ni, Leng","Di, Xiao","Ma, Baitao","Niu, Shuai","Liu, Changwei","Reiter, Russel J"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32217117","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.lfs.2020.117583","keywords":["COVID-19","Cytokines","Immunomodulation","Melatonin","Oxidation-reduction","SARS-CoV-2"],"source":"PubMed","topics":["Treatment"],"weight":1,"e_drugs":["Melatonin"],"_version_":1663352135106953216,"score":158.27193}]}